H G Burger

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 84:4025-30. 1999
  2. ncbi Hormonal changes in the menopause transition
    Henry G Burger
    Prince Henry s Institute of Medical Research at Monash Medical Centre, Clayton, Victoria, Australia
    Recent Prog Horm Res 57:257-75. 2002
  3. ncbi Androgen production in women
    Henry G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
    Fertil Steril 77:S3-5. 2002
  4. ncbi Physiological principles of endocrine replacement: estrogen
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton Road, Clayton 3168 Victoria, Australia
    Horm Res 56:82-5. 2001
  5. ncbi The inhibins and ovarian cancer
    H G Burger
    Prince Henry s Institute of Medical Research, PO Box 5152, VIC 3168, Clayton, Australia
    Mol Cell Endocrinol 180:145-8. 2001
  6. ncbi A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Center, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 85:2832-8. 2000
  7. ncbi Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Center, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 83:4167-9. 1998
  8. ncbi Bone turnover markers and bone density across the menopausal transition
    P R Ebeling
    Bone and Mineral Service, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
    J Clin Endocrinol Metab 81:3366-71. 1996
  9. ncbi Inhibins/activins as diagnostic markers for ovarian cancer
    D M Robertson
    Prince Henry s Institute of Medical Research, PO Box 5152, Clayton, VIC 3168, Australia
    Mol Cell Endocrinol 191:97-103. 2002
  10. ncbi FSH-regulated gene expression profiles in ovarian tumours and normal ovaries
    S Chu
    Prince Henry s Institute of Medical Research and the Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, 3168, Australia
    Mol Hum Reprod 8:426-33. 2002

Collaborators

Detail Information

Publications61

  1. ncbi Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 84:4025-30. 1999
    ....
  2. ncbi Hormonal changes in the menopause transition
    Henry G Burger
    Prince Henry s Institute of Medical Research at Monash Medical Centre, Clayton, Victoria, Australia
    Recent Prog Horm Res 57:257-75. 2002
    ....
  3. ncbi Androgen production in women
    Henry G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
    Fertil Steril 77:S3-5. 2002
    ..To describe the sources, production rates, circulating concentrations, and regulatory mechanisms of the major androgen precursors and androgens in women...
  4. ncbi Physiological principles of endocrine replacement: estrogen
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton Road, Clayton 3168 Victoria, Australia
    Horm Res 56:82-5. 2001
    ....
  5. ncbi The inhibins and ovarian cancer
    H G Burger
    Prince Henry s Institute of Medical Research, PO Box 5152, VIC 3168, Clayton, Australia
    Mol Cell Endocrinol 180:145-8. 2001
    ..Findings to date have been largely negative with no evidence for activating mutations of the FSH receptor or of the post-receptor signalling pathway proteins...
  6. ncbi A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Center, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 85:2832-8. 2000
    ..DHEAS decreases as a function of age, not time relative to FMP, and T remains unchanged during the menopausal years. SHBG and DHEAS show a high degree of stability within an individual over time...
  7. ncbi Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Center, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 83:4167-9. 1998
    ....
  8. ncbi Bone turnover markers and bone density across the menopausal transition
    P R Ebeling
    Bone and Mineral Service, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
    J Clin Endocrinol Metab 81:3366-71. 1996
    ..In conclusion, the perimenopause is associated with elevated bone resorption rates and declining BMD, and factors in addition to estrogen deficiency may also contribute to the pathogenesis of postmenopausal osteoporosis...
  9. ncbi Inhibins/activins as diagnostic markers for ovarian cancer
    D M Robertson
    Prince Henry s Institute of Medical Research, PO Box 5152, Clayton, VIC 3168, Australia
    Mol Cell Endocrinol 191:97-103. 2002
    ..Furthermore, based on the high sensitivity/specificity characteristics of the respective assays for the various types of ovarian cancer, the combination of the inhibin assay with CA125 detects the majority of all ovarian cancers...
  10. ncbi FSH-regulated gene expression profiles in ovarian tumours and normal ovaries
    S Chu
    Prince Henry s Institute of Medical Research and the Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, 3168, Australia
    Mol Hum Reprod 8:426-33. 2002
    ..Comparison of the gene expression profiles between each tumour group suggests a molecular phenotype for GCT that is similar to that reported for FSH stimulated pre-ovulatory granulosa cells...
  11. ncbi Combined inhibin and CA125 assays in the detection of ovarian cancer
    D M Robertson
    Prince Henry s Institute of Medical Research, Clayton, Victoria 3168, Australia
    Clin Chem 45:651-8. 1999
    ....
  12. ncbi A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project
    H G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
    Hum Reprod Update 13:559-65. 2007
    ..This review provides the background for an accompanying manuscript in which a novel approach to modelling the hormonal changes during the transition is described...
  13. ncbi Effects of 31 kDa bovine inhibin on FSH and LH in rat pituitary cells in vitro: antagonism of gonadotrophin-releasing hormone agonists
    P G Farnworth
    Medical Research Centre, Prince Henry s Hospital, Melbourne, Victoria, Australia
    J Endocrinol 119:233-41. 1988
    ..After a 3-day pretreatment, inhibin inhibited gonadotrophin release by buserelin less effectively than that by GnRH, but the pattern of antagonism was the same.(ABSTRACT TRUNCATED AT 250 WORDS)..
  14. ncbi A prospective study of bone loss in menopausal Australian-born women
    J R Guthrie
    Department of Psychiatry, Royal Melbourne Hospital, Victoria, Australia
    Osteoporos Int 8:282-90. 1998
    ..05), such that women with higher BMI had less bone loss. In conclusion, during the time of transition from peri- to post-menopause, women had accelerated BMD loss at both the hip and spine...
  15. ncbi The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project
    J R Guthrie
    Office for Gender and Health, Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia
    Climacteric 7:375-89. 2004
    ..To determine the hormonal changes relating to the menopausal transition (MT) and how these affect quality of life, bone mineral density, body composition, cardiovascular disease (CVD) risk and memory...
  16. ncbi Inhibin forms in serum from postmenopausal women with ovarian cancers
    D M Robertson
    Prince Henry s Institute of Medical Research, Clayton, Victoria, Australia
    Clin Endocrinol (Oxf) 50:381-6. 1999
    ..The aim of the study was to identify the forms of inhibin found in a range of ovarian cancers using a range of inhibin assays with varying specificities...
  17. ncbi Impaired fasting glycaemia in middle-aged women: a prospective study
    J R Guthrie
    Office for Gender and Health, The University of Melbourne, RMH, Victoria, Australia
    Int J Obes Relat Metab Disord 25:646-51. 2001
    ....
  18. ncbi Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer
    D M Robertson
    Prince Henry s Institute of Medical Research, Clayton, Victoria 3168, Australia
    J Clin Endocrinol Metab 87:816-24. 2002
    ..These new monoclonal antibody-based inhibin alphaC ELISAs now provide practical and sensitive assays suitable for evaluation as diagnostic tests for monitoring ovarian cancers...
  19. ncbi Serum C-reactive protein and plasma homocysteine levels are associated with hormone therapy use and other factors: a population-based study of middle-aged Australian-born women
    J R Guthrie
    Office for Gender and Health, Department of Psychiatry, The University of Melbourne, Victoria, Australia
    Climacteric 8:263-70. 2005
    ..CONCLUSION: In middle-aged Australian-born women, HT use was associated with increased CRP and decreased homocysteine levels. High CRP levels were also associated with high relative weight, low exercise levels and no statin medication...
  20. ncbi Inhibin/activin and ovarian cancer
    D M Robertson
    Prince Henry s Institute of Medical Research, PO 5152, Clayton, Victoria 3168, Australia
    Endocr Relat Cancer 11:35-49. 2004
    ..In order to place these findings into perspective the biology of inhibin/activin and of other members of the TGFbeta superfamily is also discussed...
  21. ncbi Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men
    C A Allan
    Prince Henry s Institute, Monash University, Clayton, Victoria 3168, Australia
    J Clin Endocrinol Metab 93:139-46. 2008
    ..Trials of testosterone therapy in aging men have demonstrated increases in fat-free mass (FFM) and skeletal muscle and decreases in fat mass (FM) but have not reported the impact of baseline body composition...
  22. ncbi Inhibins and activins: clinical advances in reproductive medicine
    Stephen Tong
    Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia
    Clin Endocrinol (Oxf) 58:115-27. 2003
  23. ncbi A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles
    David M Robertson
    Prince Henry s Institute, Monash Medical Centre, Clayton, Victoria, Australia
    Menopause 15:1139-44. 2008
    ..To characterize menstrual cycles in women in late reproductive age and the menopause transition, based on changes in serum hormone levels...
  24. ncbi Cycle and hormone changes during perimenopause: the key role of ovarian function
    Henry G Burger
    Prince Henry s Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia
    Menopause 15:603-12. 2008
    ..There is no specific endocrine marker of the early or late transition, making measurements of FSH or E2 unreliable in attempting to stage an individual with regard to approaching menopause...
  25. ncbi Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age
    David M Robertson
    Prince Henry s Institute of Medical Research, P O Box 5152, Clayton, Victoria 3168, Australia
    J Clin Endocrinol Metab 94:138-44. 2009
    ..Ovarian hormones regulate pituitary gonadotropin secretion across the menstrual cycle via negative and positive feedback mechanisms. The contribution of individual hormones is complex and is a continuing area of research...
  26. ncbi Effects of bovine 35 kDa FSH-suppressing protein on FSH and LH in rat pituitary cells in vitro: comparison with bovine 31 kDa inhibin
    D M Robertson
    Department of Anatomy, Monash University, Clayton, Victoria, Australia
    J Endocrinol 124:417-23. 1990
    ..The effect of FSP on FSH cell content after 3 days in culture was insensitive to the neutralizing effects of an inhibin antiserum.(ABSTRACT TRUNCATED AT 250 WORDS)..
  27. ncbi Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women
    S R Davis
    The Jean Hailes Foundation Research Unit, Clayton South, Victoria, Australia
    Climacteric 5:341-50. 2002
    ....
  28. ncbi Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors
    S Chu
    Prince Henry s Institute of Medical Research and the Monash University Department of Obstetrics and Gynecology, Monash Medical Center, Clayton, Victoria, Australia
    J Clin Endocrinol Metab 85:1200-5. 2000
    ..As ERbeta(cx) has been shown to be a ligand-independent antagonist of ERalpha action, the relative ratios of ERbeta(cx), ERalpha, and ERbeta may influence the response of a tumor to antiestrogen therapy...
  29. ncbi The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopause
    Henry G Burger
    Prince Henry s Institute of Medical Research, Clayton, Victoria, Australia
    Menopause 12:267-74. 2005
    ..We sought to determine whether the onset of irregular menses, marking the menopause transition, signifies the occurrence of anovulatory, potentially infertile cycles...
  30. ncbi The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study
    Janet R Guthrie
    Office for Gender and Health, Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Charles Connibere Building, Melbourne, Victoria, Australia
    Osteoporos Int 15:881-6. 2004
    ..The aim of this study was to assess the relative strength of the association of endogenous estradiol and androgens with bone loss at the lumbar spine and femoral neck during the menopausal transition...
  31. ncbi Molecular pathogenesis of granulosa cell tumours
    Peter J Fuller
    Prince Henry s Institute of Medical Research, PO Box 5152, Clayton, VIC 3168, Australia
    Mol Cell Endocrinol 191:89-96. 2002
    ..These observations provide a basis for future studies of GCT, including further characterisation of signalling pathways known to be important in the regulation of granulosa cell growth and differentiation...
  32. ncbi The ageing female reproductive axis I
    Henry G Burger
    Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Australia
    Novartis Found Symp 242:161-7; discussion 167-71. 2002
    ..In contrast, total testosterone concentrations are maintained across the menopausal transition, with a fall in sex hormone binding globulin (SHBG) and hence a rise in free testosterone...
  33. ncbi Inhibin-activin receptor subunit gene expression in ovarian tumors
    Peter J Fuller
    Prince Henry s Institute of Medical Research and Monash University, Department of Obstetrics and Gynecology, Monash Medical Center, Clayton, Victoria 3168, Australia
    J Clin Endocrinol Metab 87:1395-401. 2002
    ..Expression of betaglycan and p120 in most GCT argues against the hypothesis, but does not exclude the possibility that low or absent expression of p120 might be significant in a subset of these tumors...
  34. ncbi Reproductive hormones: ageing and the perimenopause
    David M Robertson
    Prince Henry s Institute of Medical Research, Monash Medical Center, Clayton, Victoria, Australia
    Acta Obstet Gynecol Scand 81:612-6. 2002
    ..Hormonal patterns during the luteal phase of the menstrual cycle also show changes with age but these changes are poorly understood...
  35. ncbi Inhibins and ovarian cancer
    David M Robertson
    Prince Henry s Institute of Medical Research, Monash Medical Centre, P O Box 5152, Clayton, VIC 3168, Australia
    Mol Cell Endocrinol 225:65-71. 2004
    ..These studies are providing a platform for the introduction of the test into clinical practice...
  36. ncbi Evidence-based assessment of the impact of the WHI on women's health
    H G Burger
    Prince Henry s Institute of Medical Research, Clayton, Victoria, Australia
    Climacteric 15:281-7. 2012
    ..The results of the re-analyses of the WHI data and new data from other studies do not justify the continuing negative attitude to HRT in symptomatic women who start HRT near menopause...
  37. ncbi Response of serum inhibin B and pro-alphaC levels to gonadotrophic stimulation in normal men before and after steroidal contraceptive treatment
    Kati L Matthiesson
    Prince Henry's Institute of Medical Research, Monash Medical Centre, Monash University, Clayton, Victoria 3168, Australia
    Hum Reprod 18:734-43. 2003
    ....
  38. ncbi Central abdominal fat and endogenous hormones during the menopausal transition
    Janet R Guthrie
    Office for Gender and Health, Royal Melbourne Hospital, Victoria, Australia
    Fertil Steril 79:1335-40. 2003
    ..To investigate the effect of endogenous hormone levels on central abdominal fat during the menopausal transition in a population-based cohort of Australian-born women...
  39. ncbi Mammographic densities during the menopausal transition: a longitudinal study of Australian-born women
    Janet R Guthrie
    Office for Gender and Health, Department of Psychiatry, The University of Melbourne, and St Vincent s BreastScreen, St Vincent s Hospital, Victoria, Australia
    Menopause 14:208-15. 2007
    ..The objective of this study was to investigate hormonal and other factors associated with mammographic density during the menopausal transition and in postmenopause...
  40. ncbi Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study
    Janet R Guthrie
    Office for Gender and Health, Department of Psychiatry, University of Melbourne, RMH, Victoria, Australia
    Menopause 11:315-22. 2004
    ....
  41. ncbi Hot flushes during the menopause transition: a longitudinal study in Australian-born women
    Janet R Guthrie
    Office for Gender and Health, Department of Psychiatry, The University of Melbourne, Victoria, Australia
    Menopause 12:460-7. 2005
    ..To investigate factors associated with the presence, severity, and frequency of hot flushes...
  42. ncbi Androgen insufficiency in women: diagnostic and therapeutic implications
    L M Rivera-Woll
    The Jean Hailes Foundation Research Unit, 173 Carinish Road, Clayton, Victoria, Australia, 3168
    Hum Reprod Update 10:421-32. 2004
    ..There is a need for formulations of testosterone therapy specifically designed for use in women, along with clear guidelines regarding optimal therapeutic doses and long-term safety data...
  43. ncbi A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire
    Henry G Burger
    The Jean Hailes Foundation, Clayton, Australia
    Sex Health 3:73-8. 2006
    ..Currently, available methods include testosterone implants and testosterone creams, and transdermal patches and sprays are in development...
  44. ncbi Modeling women's health during the menopausal transition: a longitudinal analysis
    Lorraine Dennerstein
    Office for Gender and Health, Department of Psychiatry, The University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
    Menopause 14:53-62. 2007
    ....
  45. ncbi The role of androgen therapy
    Henry G Burger
    Prince Henry's Institute of Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia
    Best Pract Res Clin Obstet Gynaecol 16:383-93. 2002
    ..Clinical symptoms of androgen deficiency include lethargy, tiredness and loss of sex drive and interest, and have responded well to androgen replacement, generally without significant side-effects...
  46. ncbi A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women
    Joanne Ryan
    Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Menopause 16:509-17. 2009
    ..Across a woman's lifetime, variations in hormone levels are known to influence mood and well-being. Whether absolute or changes in hormone levels over time are associated with depression among postmenopausal women remains unclear...
  47. ncbi Surgical or medical treatment of polycystic ovary syndrome: a cost-benefit analysis
    G T Kovacs
    Ovulation Induction Service, Department of Obstetrics and Gynaecology, Monash University, Prince Henry's Institute of Medical Research, Victoria, Australia
    Gynecol Endocrinol 16:53-5. 2002
    ..Because of the potential advantages of ovarian cautery, we recommend this surgery as the next line of treatment if clomiphene citrate fails to induce ovulation in PCOS patients, before gonadotropins are introduced...
  48. ncbi The role of androgen therapy
    Susan R Davis
    The Jean Hailes Research Unit, Clayton, Victoria, Australia
    Best Pract Res Clin Endocrinol Metab 17:165-75. 2003
    ..Clinical symptoms of androgen insufficiency include loss of libido, diminished well-being, fatigue and blunted motivation and have been reported to respond well to T replacement, generally without significant side-effects...
  49. ncbi WHI risks: any relevance to menopause management?
    Henry G Burger
    Prince Henry s Institute and Jean Hailes Foundation For Women s Health, Clayton, Victoria, Australia
    Maturitas 57:6-10. 2007
    ..Other risks are analysed similarly...
  50. ncbi Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial
    M Diana van Die
    School of Health Sciences, RMIT University, Bundoora, Victoria, Australia
    BMC Med Res Methodol 9:41. 2009
    ..A substantial placebo response was observed but no significant difference in efficacy between the two arms...
  51. ncbi Hormone therapy in the WHI era
    Henry G Burger
    Prince Henry s Institute of Medical Research and Jean Hailes Foundation for Women s Health, Clayton, Victoria, Australia
    Aust N Z J Obstet Gynaecol 46:84-91. 2006
    ..Tibolone has emerged as an alternative treatment for menopausal symptoms, but its long-term benefits and risks have yet to be documented...
  52. ncbi Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause
    Margaret Diana van Die
    Royal Melbourne Institute of Technology University, Bundoora, Victoria, Australia
    Menopause 16:792-6. 2009
    ..The aim of this study was to evaluate predictors of the placebo response in a randomized, placebo-controlled, double-blind trial of a phytotherapeutic combination for the treatment of menopausal symptoms...
  53. ncbi Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints
    Margaret Diana van Die
    Royal Melbourne Institute of Technology RMIT University, Bundoora, Victoria, Australia
    J Altern Complement Med 15:853-62. 2009
    ..Here we review the evidence for this application of Vitex based on evidence from pharmacological studies and clinical research...
  54. ncbi Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial
    M Diana van Die
    Royal Melbourne Institute of Technology University, Victoria, Australia
    Menopause 16:156-63. 2009
    ..To evaluate the effectiveness of a phytotherapeutic intervention comprising a combination of Hypericum perforatum (St. John's wort) and Vitex agnus-castus (Chaste tree/berry) in the management of menopausal symptoms...
  55. ncbi Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant
    Catherine S Choong
    Department of Pediatric Endocrinology, Mater Misericordiae Hospitals, South Brisbane, Queensland 4104, Australia
    J Clin Endocrinol Metab 87:49-56. 2002
    ....
  56. ncbi New findings from non-linear longitudinal modelling of menopausal hormone changes
    Lorraine Dennerstein
    Office for Gender and Health, Department of Psychiatry, Royal Melbourne Hospital Melbourne, The University of Melbourne, Victoria 3050, Australia
    Hum Reprod Update 13:551-7. 2007
    ..These findings have clinical relevance in identifying which symptoms will be triggered by steep transitions of E2 such as sudden withdrawal and which health parameters may require a maintenance level of E2...
  57. ncbi Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system
    Georgina E Hale
    Department of Obstetrics and Gynecology, University of Sydney, New South Wales, Australia 2006
    J Clin Endocrinol Metab 92:3060-7. 2007
    ..Female reproductive aging based on changes in menstrual cycle length and frequency progresses through a number of stages as defined by the Stages of Reproductive Aging Workshop (STRAW) staging criteria...
  58. ncbi The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men
    Carolyn A Allan
    Prince Henry's Institute, Melbourne, Vic, Australia
    Med J Aust 185:424-7. 2006
    ..Studies of testosterone therapy in this group of ageing men are needed to determine whether androgen replacement is beneficial...
  59. ncbi Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause
    Britt-Marie Landgren
    Department of Clinical Science, Division of Obstetrics and Gynaecology, Karolinska Institutet, Huddinge University Hospital, SE-14186 Stockholm, Sweden
    J Clin Endocrinol Metab 89:2763-9. 2004
    ..The data amplify and clarify current concepts of the endocrine basis of the menopause transition...
  60. ncbi Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone
    Pierre-Marc G Bouloux
    Department of Endocrinology, The Royal Free Hospital, London, United Kingdom
    J Androl 24:604-11. 2003
    ..In conclusion, a weekly dose of 450 IU (3 x 150 IU or 2 x 225 IU) recFSH, in addition to hCG, was able to induce spermatogenesis in many hypogonadotropic azoospermic men who failed to respond to treatment with hCG alone...
  61. ncbi Should testosterone be added to estrogen-progestin therapy for breast protection?
    Henry G Burger
    Menopause 14:159-62. 2007